In the near future in Russia will need to a vaccine against coronavirus infection COVID-19 to 50 million people – every third resident of the country. This assessment gave the head of the Russian direct investment Fund Kirill Dmitriev.
In an interview with the information centre stopmanager. Russia Dmitriev reminded that the domestic vaccine has successfully passed the first stage of clinical trials and in early August can go to the third phase.
“Just, according to our estimates, in the Russian Federation it is necessary in the near future to vaccinate 40-50 million people”, – he stated.
Mass production of the vaccine, if approved, regulators will start at the sites of the companies RDIF R-Pharm and Alium, and by September, the permits may be issued in other partner countries.
“Mass production of this vaccine will be able to stop a potential “second wave” of the pandemic. First, we’ll need Russia, but international cooperation is an important part of the design and conduct of clinical trials”, – said Dmitriev.